Mandate

Vinge advises Industrifonden in connection with the investment round in Amra

January 24, 2017

Vinge has advised Industrifonden in connection with an investment round of USD 9 million for the digital health company Advanced MR Analytics AB (AMRA).

The investment round was led by Pfizer Venture Investments and VC Novo Seeds together with the existing investor Industrifonden.

AMRA has developed a method for measuring body fat and muscle mass using a magnetic camera. The company’s aim is to assess the risk of serious illness based upon the patient’s body profile. The investment round facilitates an international establishment and an expanded network among leading pharmaceutical companies.

Vinge’s team consisted of Johan Larsson and Johan Mattsson.

Related

Vinge advises Aspo on its acquisition of Swed Handling

Vinge advises Aspo, listed on Nasdaq Helsinki, in the transaction whereby Aspo's subsidiary Telko expands its chemicals business in Sweden by acquiring Swed Handling, a leading Swedish chemical distributor, from TeRa Invest. As part of the transaction, Aspo’s subsidiary Leipurin expands its food industry business in Sweden, via the technical food ingredient distributor Kebelco, which is a subsidiary of Swed Handling. The closing of the transaction is subject to customary regulatory approvals.
April 30, 2024

Vinge advises on the sale of Vinnergi Holding AB

Vinge has advised Sobro and other shareholders in connection with the sale of Vinnergi Holding AB to Polaris, a Nordic investment firm. In connection with the transaction, the management and employees are reinvesting a significant portion to further develop the company. The Vinnergi Group conducts operations in technology consulting and software development in Sweden, with a particular focus on telecoms, energy and real estate.
April 30, 2024

Vinge has advised Pareto Securities in connection with a rights issue in Episurf Medical

Vinge has advised Pareto Securities in connection with a partially secured rights issue of units of up to approximately SEK 120 million in Episurf Medical.
April 24, 2024